- Visibility 519 Views
- Downloads 611 Downloads
- Permissions
- DOI 10.18231/j.ijogr.v.12.i.3.34
-
CrossMark
Retained products of conception: A challenging case
- Author Details:
-
Sukesh Kumar Kathpalia *
Sukesh Kumar Kathpalia *
Retained products of conception is a condition where some remnants of trophoblast or placenta are retained after spontaneous or induced abortion especially medical or after delivery; vaginal or caesarean. These retained products cause bleeding and is source of infection. The diagnosis is based on clinical presentation and sonography, sometimes some patients may require other modes of imaging. There are different modalities of treatment, hysteroscopic removal is claimed to be superior to others. We present a case of retained products after medical methods of termination of pregnancy in a case of chronic myeloid leukaemia. The diagnosis was made on clinical history and confirmed on sonography. The patient had marked pancytopenia and was managed conservatively aided by prostaglandins along with serial measurement of β human chorionic gonadotrophins. Fertility, pregnancy and contraception are important parts of the management of chronic myeloid leukaemia and other malignancies as the survival rates are improving with new modalities of treatment.
References
- Guarino A, Di Benedetto L, Assorgi C, Rocca A, Caserta D. Conservative and timely treatment in retained products of conception: a case report of placenta accreta ritention. Int J Clin Exp Pathol. 2015;8(10):13625–9.
- Romero R, Hsu YC, Athanassiadis AP, Hagay Z, Avila C, Nores J, et al. Preterm delivery: a risk factor for retained placenta. Am J Obstet Gynecol. 1990;163(3):823–5.
- Kishimoto N, Miyamoto M, Imauji A, Takada M, Nishitani S, Tanabe R, et al. Clinical significance of retained products of conception in placenta previa: a retrospective analysis. BMC Pregnancy Childbirth. 2023;23(1):481.
- Sellmyer MA, Desser TS, Maturen KE, Jeffrey Jr RB, Kamaya A. Physiologic, histologic, and imaging features of retained products of conception. Radiographics. 2013;33(3):781–96.
- Chaudhary P, Sharma S, Yadav R, Dhaubhadel P. B-Lynch brace suture: an effective method of conservative surgical management for placenta increta. Kathmandu Univ Med J (KUMJ). 2004;2(2):149–
- Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458–61.
- Iraha Y, Okada M, Toguchi M, Azama K, Mekaru K, Kinjo T, et al. Multimodality imaging in secondary postpartum or postabortion hemorrhage: retained products of conception and related conditions. Jpn J Radiol. 2018;36(1):12–22.
- Li Q, Zhang W, Hu C, Zhao Y, Pei C, Wu X, et al. Termination of a second-trimester pregnancy with placenta accreta spectrum disorder. Libyan J Med. 2023;18(1):2258669.
- Chawla S, Sharma R. Retained products of conception (RPOC): Diagnosis, complication & management. J Obstet Gynaecol India. 2023;73(5):374–80.
- Wolman I, Gordon D, Yaron Y, Kupferminc M, Lessing JB, Jaffa AJ. Transvaginal sonohysterography for the evaluation and treatment of retained products of conception. Gynecol Obstet Invest. 2000;50(2):73–6.
- Herman HG, Kogan Z, Tairy D, Ben Zvi M, Kerner R, Ginath S, et al. Pregnancies Following Hysteroscopic Removal of Retained Kathpalia / Indian Journal of Obstetrics and Gynecology Research 2025;12(3):576–579 579 Products of Conception after Delivery Versus Abortion. Gynecol Obstet Invest. 2018;83(6):586–92.
- van den Bosch T, Daemen A, Van Schoubroeck D, Pochet N, De Moor B, Timmerman D. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med. 2008;27(3):357–61.
- Fejgin MD, Shvit TY, Gershtansky Y, Biron-Shental T. Retained placental tissue as an emerging cause for malpractice claims. Isr Med Assoc J. 2014;16(8):502–5.
- Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014;173:19–22.
- Barel O, Krakov A, Pansky M, Vaknin Z, Halperin R, Smorgick N. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors? Fertil Steril. 2015;103(3):775–9.
- Golan A, Dishi M, Shalev A, Keidar R, Ginath S, Sagiv R. Operative hysteroscopy to remove retained products of conception: novel treatment of an old problem. J Minim Invasive Gynecol. 2011;18(1):100–3.
- Iqbal J, Ali Z, Khan A-UN, Aziz Z. Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country. Leuk Lymphoma. 2014;55(9):2109–13.
- Wang Y, Jiang L, Li B, Zhao Y. Management of chronic myeloid leukemia and pregnancy: A bibliometric analysis (2000-2020). Front Oncol. 2022;12:826703.